| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $16.9B | $15.1B | $15.3B | $19.2B | $16.6B | $11.7B | $13.2B | $14.1B |
| Cost of Revenue | — | — | — | $9.3B | $6.5B | $2.5B | $3.3B | $4.4B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $4.7B | $4.4B | $4.3B | $4.1B | $2.9B | $1.6B | $4.9B | $3.8B |
| Net Income | $3.1B | $2.6B | $2.4B | $2.5B | $1.8B | $0.1B | $2.2B | $1.6B |
| EPS (Basic) | $1.37 | $1.17 | $1.06 | $1.12 | $0.78 | — | — | — |
| EPS (Diluted) | $1.37 | $1.17 | $1.06 | $1.12 | $0.78 | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $72.7B | $71.4B | $71.0B | $70.1B | $70.4B | $72.0B | $74.2B | $78.9B |
| Current Assets | $2.8B | $2.5B | $2.5B | $3.8B | $3.8B | $3.2B | $3.2B | $5.7B |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.7B | $1.1B | $1.2B | $0.2B | $3.3B |
| Total Liabilities | $40.3B | $39.5B | $39.3B | $38.0B | $38.5B | $39.4B | $39.3B | $43.7B |
| Current Liabilities | $4.3B | $5.1B | $7.2B | $6.9B | $5.8B | $5.1B | $5.1B | $7.6B |
| Stockholders' Equity | $31.2B | $30.5B | $30.3B | $30.7B | $30.8B | $31.4B | $33.7B | $33.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.9B | $5.6B | $6.5B | $5.0B | $5.7B | $4.5B | $4.7B | $5.0B |
| Investing Cash Flow | $-3.2B | $-2.6B | $-4.2B | $-2.2B | $-2.3B | $-0.9B | $-1.7B | $-0.1B |
| Capital Expenditures | $3.0B | $2.6B | $2.3B | $1.6B | $1.3B | $1.7B | $2.3B | $2.9B |
| Financing Cash Flow | $-2.8B | $-2.9B | $-3.0B | $-3.1B | $-3.5B | $-2.6B | $-6.2B | $-1.8B |